Skip to main content

Vasoplegia clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Angiotensin II in Liver Transplantation

    Sorry, not yet accepting patients

    The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.

    San Francisco, California

Last updated: